Fusion Pharm Company Leadership
| FSPM Stock | USD 0.0001 0.00 0.00% |
Fusion Pharm employs about 4 people. The company is managed by 2 executives with a total tenure of roughly 10 years, averaging almost 5.0 years of service per executive, having 2.0 employees per reported executive. Analysis of Fusion Pharm's management performance can provide insight into the firm performance.
Fusion |
Fusion Pharm Management Team Effectiveness
The company has return on total asset (ROA) of (1.3769) % which means that it has lost $1.3769 on every $100 spent on assets. This is way below average. Fusion Pharm's management efficiency ratios could be used to measure how well Fusion Pharm manages its routine affairs as well as how well it operates its assets and liabilities.Fusion Pharm Workforce Comparison
Fusion Pharm is one of the top stocks in number of employees category among its peers. The total workforce of Consumer Staples industry is currently estimated at about 428. Fusion Pharm maintains roughly 4.0 in number of employees contributing less than 1% to stocks in Consumer Staples industry.
The company has Profit Margin (PM) of (1.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.24) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.24. Fusion Pharm Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Fusion Pharm Price Series Summation is a cross summation of Fusion Pharm price series and its benchmark/peer.
Fusion Pharm Notable Stakeholders
A Fusion Pharm stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Fusion Pharm often face trade-offs trying to please all of them. Fusion Pharm's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Fusion Pharm's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| William Sears | Chief Officer | Profile | |
| Andrew Duke | Ex VP | Profile |
About Fusion Pharm Management Performance
The success or failure of an entity such as Fusion Pharm often depends on how effective the management is. Fusion Pharm management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Fusion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Fusion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in the United States. The company was founded in 1998 and is based in Commerce City, Colorado. Fusion Pharm operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 4 people.
Fusion Pharm Workforce Analysis
Traditionally, organizations such as Fusion Pharm use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Fusion Pharm within its industry.Fusion Pharm Manpower Efficiency
Return on Fusion Pharm Manpower
| Revenue Per Employee | 148.6K | |
| Revenue Per Executive | 297.2K | |
| Net Loss Per Employee | 10.5K | |
| Net Loss Per Executive | 21K | |
| Working Capital Per Employee | 182K | |
| Working Capital Per Executive | 364K |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fusion Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion Pharm. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.